Stock Scorecard
Stock Summary for Qiagen NV (QGEN) - $39.85 as of 3/28/2025 8:49:04 PM EST
Total Score
9 out of 30
Safety Score
54 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for QGEN
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for QGEN
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for QGEN
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for QGEN
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for QGEN (54 out of 100)
Stock Price Rating (Max of 10) | 8 |
Historical Stock Price Rating (Max of 10) | 9 |
Stock Price Trend (Max of 10) | 2 |
Book Value (Max of 10) | 6 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 5 |
Analyst Strong Buy Ratings (Max of 5) | 4 |
Dividend Yield Percentage (Max of 10) | 6 |
Operating Margin (Max of 10) | 5 |
Trading Volume (Max of 10) | 8 |
Price to Earnings (Max of 10) | 1 |
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for QGEN
Financial Details for QGEN
Company Overview |
|
---|---|
Ticker | QGEN |
Company Name | Qiagen NV |
Country | USA |
Description | QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally. The company is headquartered in Venlo, the Netherlands. |
Sector Name | LIFE SCIENCES |
Industry Name | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
Most Recent Quarter | 12/31/2024 |
Next Earnings Date | 4/30/2025 |
Stock Price History |
|
Last Day Price | 39.85 |
Price 4 Years Ago | 55.67 |
Last Day Price Updated | 3/28/2025 8:49:04 PM EST |
Last Day Volume | 868,833 |
Average Daily Volume | 1,077,563 |
52-Week High | 47.96 |
52-Week Low | 37.63 |
Last Price to 52 Week Low | 5.90% |
Valuation Measures |
|
Trailing PE | 104.16 |
Industry PE | 53.93 |
Sector PE | 40.10 |
5-Year Average PE | 21.61 |
Free Cash Flow Ratio | 12.98 |
Industry Free Cash Flow Ratio | 18.14 |
Sector Free Cash Flow Ratio | 47.05 |
Current Ratio Most Recent Quarter | 3.61 |
Total Cash Per Share | 3.07 |
Book Value Per Share Most Recent Quarter | 16.05 |
Price to Book Ratio | 2.40 |
Industry Price to Book Ratio | 11.03 |
Sector Price to Book Ratio | 21.92 |
Price to Sales Ratio Twelve Trailing Months | 4.33 |
Industry Price to Sales Ratio Twelve Trailing Months | 59.91 |
Sector Price to Sales Ratio Twelve Trailing Months | 27.78 |
Analyst Buy Ratings | 5 |
Analyst Strong Buy Ratings | 4 |
Share Statistics |
|
Total Shares Outstanding | 216,115,000 |
Market Capitalization | 8,612,182,750 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | 1/29/2025 |
Previous Dividend Amount | 1.2960 |
Current Dividend Amount | 1.3166 |
Total Years Dividend Increasing | 0 |
Trailing Annual Dividend Rate | 1.32 |
Trailing Annual Dividend Yield | 3.31% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 2 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | 346.47% |
Income Statement |
|
Quarterly Earnings Growth YOY | -9.90% |
Annual Earnings Growth | -75.51% |
Reported EPS 12 Trailing Months | 0.38 |
Reported EPS Past Year | 2.19 |
Reported EPS Prior Year | 2.07 |
Net Income Twelve Trailing Months | 83,591,000 |
Net Income Past Year | 83,591,000 |
Net Income Prior Year | 341,303,000 |
Quarterly Revenue Growth YOY | 2.40% |
5-Year Revenue Growth | 5.32% |
Operating Margin Twelve Trailing Months | 27.70% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 663,555,000 |
Total Cash Past Year | 663,555,000 |
Total Cash Prior Year | 668,084,000 |
Net Cash Position Most Recent Quarter | -701,029,000 |
Net Cash Position Past Year | -258,269,000 |
Long Term Debt Past Year | 921,824,000 |
Long Term Debt Prior Year | 921,824,000 |
Total Debt Most Recent Quarter | 1,364,584,000 |
Equity to Debt Ratio Past Year | 0.79 |
Equity to Debt Ratio Most Recent Quarter | 0.72 |
Total Stockholder Equity Past Year | 3,567,339,000 |
Total Stockholder Equity Prior Year | 3,807,764,000 |
Total Stockholder Equity Most Recent Quarter | 3,567,339,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | 503,274,000 |
Free Cash Flow Per Share Twelve Trailing Months | 2.33 |
Free Cash Flow Past Year | 506,377,000 |
Free Cash Flow Prior Year | 296,653,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.36 |
MACD Signal | -0.61 |
20-Day Bollinger Lower Band | 37.45 |
20-Day Bollinger Middle Band | 42.48 |
20-Day Bollinger Upper Band | 47.51 |
Beta | 0.44 |
RSI | 51.21 |
50-Day SMA | 43.19 |
150-Day SMA | 44.39 |
200-Day SMA | 46.01 |
System |
|
Modified | 3/28/2025 5:35:10 AM EST |